Arcutis Biotherapeutics Spotlights ZORYVE Surge, 2025 Revenue Beat and Key FDA Milestones at TD Cowen

Watanabe also noted the company is ending its primary care partnership and bringing those efforts in-house, building dedicated primary care and pediatric sales capabilities alongside the dermatology team. Edwards said Arcutis aims to have both the dermatology expansion and an initial 30-person primary care/pediatrics team hired, onboarded, and in the field by July 1 . He said dermatology productivity typically shows impact in about three months, while primary care and pediatrics may take longer, likely into ...